📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-27 19:07
0 analysed today
FollowTelegram
0
Today
151,859
All-time analysed
43,535
Positive
6,743
Negative
92,744
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
5 announcements match the current filters (relevance ≥ 5).
Osel Devices CFO Resigns; Board Clears ₹50 Cr RPT Limit & Authorised Capital Hike to ₹25 Cr
Osel Devices announced that its Whole-time Director and CFO, Mrs. Jyotsna Jawahar, has resigned effective August 27, 2026, citing maternity commitments. The Board approved the re-appointment of Managing Director Mr. Rajendra Ravi Shanker Mishra and Whole-time Director Mr. Mukesh Kumar Sinha for a three-year term from January 16, 2027 to January 15, 2030, subject to shareholder approval. Additionally, the Board approved increasing the authorised share capital from ₹20.00 crore to ₹25.00 crore and cleared material related-party transactions with Guardian Technologies up to ₹50 crore for FY 2026-27. The company's 20th Annual General Meeting is scheduled for September 25, 2026.
Confidence: HIGH
What changedCFO Jyotsna Jawahar resigned due to maternity; the Board approved key director re-appointments, an increase in authorised share capital, and a ₹50 crore RPT limit.
Why it mattersFilling the CFO vacancy smoothly is critical for ongoing financial reporting and governance, while the capital expansion and RPT approvals support ongoing operations.
Related Party Transaction Limit: Rs. 50 CroreExisting Authorised Capital: Rs. 20,00,00,000Proposed Authorised Capital: Rs. 25,00,00,000MD/WTD Re-appointment Tenure: 3 years (w.e.f Jan 16, 2027)AGM Date: September 25, 2026
📅 Short termMarket focus will be on the company's interim finance leadership and the timeline for appointing a permanent CFO.
📈 Long termRe-appointment of executive leadership ensures management continuity across the core LED display and hearing aid business segments.
⚠ Risk flags
- Key managerial vacancy following the resignation of the CFO
- Large related-party transaction limit (up to ₹50 Cr) with Guardian Technologies
Key Highlights
Resignation of Mrs. Jyotsna Jawahar as Whole-time Director and CFO effective close of business on August 27, 2026 due to maternity
Approval of material Related Party Transactions with Guardian Technologies up to ₹50 Crore for FY 2026-27
Increase in Authorised Share Capital from ₹20.00 Crore to ₹25.00 Crore by creating 50,00,000 equity shares of ₹10 each
Re-appointment of MD Rajendra Ravi Shanker Mishra and WTD Mukesh Kumar Sinha for 3 years starting January 16, 2027
20th Annual General Meeting convened for September 25, 2026 via video conference
👀 What to Watch
Track the announcement of a successor CFO and monitor shareholder voting results on the RPT and capital expansion resolutions at the AGM on September 25, 2026.
Osel Devices Board Approves Rs 50 Cr Related Party Deals, Sub Merger & Notes CFO Resignation
Osel Devices Limited has announced multiple key board decisions on August 27, 2026. Key actions include approving a material related-party transaction limit of up to Rs 50 Crore with Guardian Technologies for FY 2026-27, alongside the merger of its subsidiary Osel Healthcare Private Limited into step-down subsidiary SFL Hearing Solutions Private Limited. Additionally, the company is increasing its authorised share capital from Rs 20 Crore to Rs 25 Crore and updating its MOA object clause to formalise mobile phone and hearing aid operations. The board also accepted the resignation of CFO and Whole-Time Director Mrs. Jyotsna Jawahar due to maternity.
Confidence: HIGH
What changedOsel Devices restructured internal subsidiaries, expanded authorised share capital by Rs 5 Crore, sanctioned Rs 50 Crore in related-party transactions, and acknowledged the departure of its CFO.
Why it mattersThe internal merger streamlines the hearing solutions segment, while raising the authorised share capital creates headroom for potential equity issuance or fundraises. The resignation of the CFO requires monitoring for leadership transition.
RPT Limit with Guardian Technologies: Rs 50 CroreAuthorised Share Capital (Old): Rs 20,00,00,000Authorised Share Capital (New): Rs 25,00,00,000AGM Date: September 25, 2026
📅 Short termFocus will remain on the upcoming AGM for shareholder approvals and the appointment of a new Chief Financial Officer.
📈 Long termConsolidation of healthcare/hearing subsidiaries simplifies group structure, aligning with its expanded MOA business objects in consumer electronics and hearing aids.
⚠ Risk flags
- Key managerial transition following the resignation of the Chief Financial Officer.
- Significant related-party transaction limit of up to Rs 50 Crore.
Key Highlights
Approved material related-party transactions with Guardian Technologies up to Rs 50 Crore for FY 2026-27.
Proposed merger of subsidiary Osel Healthcare Private Limited with step-down subsidiary SFL Hearing Solutions Private Limited.
Increased authorised share capital from Rs 20.00 Crore (2.00 Crore shares) to Rs 25.00 Crore (2.50 Crore shares).
Whole-Time Director & CFO Mrs. Jyotsna Jawahar resigned effective August 27, 2026, due to maternity.
Re-appointed MD Rajendra Ravi Shanker Mishra and WTD Mukesh Kumar Sinha for 3-year terms effective January 16, 2027.
👀 What to Watch
Track the appointment of a replacement CFO and shareholder voting outcomes on the Rs 50 Crore RPT limit and capital expansion at the AGM on September 25, 2026.
Osel Devices Board Approves Capital Hike to ₹25 Cr, ₹50 Cr RPT & Notes CFO Resignation
Osel Devices announced several key board decisions on August 27, 2026, including the resignation of Whole-Time Director & CFO Mrs. Jyotsna Jawahar effective immediately due to maternity. The board approved increasing the authorised share capital from ₹20.00 crore to ₹25.00 crore and sanctioned material related-party transactions with Guardian Technologies up to ₹50.00 crore for FY 2026-27, subject to shareholder approval. Additionally, the re-appointments of MD Rajendra Ravi Shanker Mishra and WTD Mukesh Kumar Sinha were approved for a three-year term from January 2027, along with an amendment to the MOA object clause covering mobile phones and hearing aids.
Confidence: HIGH
What changedThe company cleared leadership re-appointments, expanded its authorised capital base, formalised its business object clause, and accepted the resignation of its sitting CFO.
Why it mattersThe ₹5.00 crore increase in authorised capital creates headroom for potential equity issuance or corporate actions, while the ₹50.00 crore RPT approval structures supply chain transactions for FY 2026-27.
Authorised Capital (Post-Hike): ₹25,00,00,000Authorised Capital (Pre-Hike): ₹20,00,00,000Approved RPT Limit (FY 2026-27): ₹50 CroreRe-appointment Tenure (MD & WTD): 3 years (Jan 16, 2027 to Jan 15, 2030)Annual General Meeting Date: September 25, 2026
📅 Short termNeutral market impact expected as CFO departure is amicable due to personal reasons; the focus will shift to finding a replacement CFO and AGM voting outcomes.
📈 Long termThe alignment of MOA objects to smartphones and hearing aids solidifies the company's recent strategic diversification into feature phones and healthcare devices.
⚠ Risk flags
- Key management vacancy following the resignation of the Chief Financial Officer.
- High volume of related-party transactions (₹50 Crore limit) requires ongoing governance monitoring.
Key Highlights
CFO and Whole-Time Director Mrs. Jyotsna Jawahar resigned effective August 27, 2026, citing maternity leave with no operational disagreements.
Authorised share capital raised by ₹5.00 crore from ₹20.00 crore (2.00 crore shares) to ₹25.00 crore (2.50 crore shares of ₹10 each).
Material Related Party Transactions approved with Guardian Technologies Pvt Ltd for up to ₹50.00 crore during FY 2026-27.
Managing Director Rajendra Ravi Shanker Mishra and WTD Mukesh Kumar Sinha re-appointed for 3 years from January 16, 2027 to January 15, 2030.
Approved internal merger of subsidiary Osel Healthcare Pvt Ltd into step-down subsidiary SFL Hearing Solutions Pvt Ltd.
👀 What to Watch
Track the upcoming AGM on September 25, 2026 for shareholder voting on the capital increase and RPT, along with announcements regarding the appointment of a new Chief Financial Officer.
Osel Devices CFO Jyotsna Jawahar Resigns; Board Approves ₹50 Cr RPT & Capital Increase to ₹25 Cr
Osel Devices announced that Mrs. Jyotsna Jawahar has resigned from her position as Whole-time Director and CFO effective August 27, 2026, citing maternity reasons with no operational disagreements. In the same board meeting, the company approved the re-appointment of MD Rajendra Ravi Shanker Mishra and WTD Mukesh Kumar Sinha for 3-year terms starting January 16, 2027. Additionally, the board approved an increase in authorized share capital from ₹20 Crore to ₹25 Crore and cleared material related-party transactions with Guardian Technologies up to ₹50 Crore for FY 2026-27, subject to shareholder approval at the AGM on September 25, 2026.
Confidence: HIGH
What changedMrs. Jyotsna Jawahar stepped down as CFO and Whole-time Director, while the board cleared a ₹5 Crore hike in authorized capital and ₹50 Crore related-party transactions.
Why it mattersThe exit of the CFO requires a transition in financial leadership, while the authorized capital expansion provides headroom for potential future equity fundraising.
Authorized Capital Increase: ₹25,00,00,000Previous Authorized Capital: ₹20,00,00,000Related Party Transaction Limit (FY27): ₹50 CroreMD Re-appointment Tenure: 3 years (Jan 16, 2027 to Jan 15, 2030)AGM Date: September 25, 2026
📅 Short termNeutral impact expected as the CFO resignation is explicitly on personal/maternity grounds with confirmed absence of material disagreements.
📈 Long termLimited operational disruption provided a competent successor CFO is appointed swiftly; the amended MOA clauses support expansion into mobile phones and hearing aids.
⚠ Risk flags
- Key managerial vacancy at the CFO position
- Material related-party exposure of up to ₹50 Crore with Guardian Technologies Private Limited
Key Highlights
CFO & Whole-Time Director Mrs. Jyotsna Jawahar resigned effective August 27, 2026, due to maternity.
Authorized share capital increased by ₹5.00 Crore from ₹20.00 Crore to ₹25.00 Crore via 50 lakh additional equity shares of ₹10 each.
Material related-party transactions up to ₹50.00 Crore approved with Guardian Technologies Pvt Ltd for FY 2026-27.
Re-appointment of MD Rajendra Ravi Shanker Mishra and WTD Mukesh Kumar Sinha for 3 years from January 16, 2027 to January 15, 2030.
20th Annual General Meeting scheduled for September 25, 2026.
👀 What to Watch
Track the appointment of a new Chief Financial Officer and monitor shareholder voting outcomes on the ₹50 Crore related-party transaction and capital increase at the September 25, 2026 AGM.
Osel Devices Approves Rs 50 Cr Related Party Limit, Capital Hike; CFO Resigns on Maternity
Osel Devices held a board meeting approving several key corporate decisions ahead of its AGM on September 25, 2026. The board approved material Related Party Transactions with Guardian Technologies up to Rs 50 Crore for FY27 and proposed increasing authorized share capital from Rs 20 Crore to Rs 25 Crore. Additionally, Mrs. Jyotsna Jawahar resigned as Whole-time Director and CFO effective August 27, 2026, due to maternity. An internal merger of subsidiary Osel Healthcare into step-down unit SFL Hearing Solutions was also approved.
Confidence: HIGH
What changedCFO Jyotsna Jawahar stepped down due to maternity; the board approved raising authorized share capital to Rs 25 Crore and authorized Rs 50 Crore in related party transactions.
Why it mattersThe capital expansion gives headroom for future equity financing, while internal subsidiary consolidation streamlines hearing aid operations, though a replacement CFO will need to be appointed.
Material RPT Limit (FY27): Rs 50 CroreNew Authorised Share Capital: Rs 25,00,00,000Existing Authorised Share Capital: Rs 20,00,00,00020th AGM Date: September 25, 2026
📅 Short termNeutral market impact expected; investor focus will remain on the transition to a new CFO and AGM approvals.
📈 Long termStreamlining hearing aid subsidiaries and expanding MOA object clauses support multi-product electronics expansion plans.
⚠ Risk flags
- Material related-party transaction limit of Rs 50 Crore with Guardian Technologies
- Vacant CFO position requiring timely leadership transition
Key Highlights
Approved Material Related Party Transactions with Guardian Technologies up to Rs 50 Crore for FY 2026-27, subject to shareholder approval
Authorised share capital proposed to be increased from Rs 20.00 Crore to Rs 25.00 Crore by creating 50 lakh additional equity shares of Rs 10 each
CFO and Whole-time Director Mrs. Jyotsna Jawahar resigned effective August 27, 2026 due to maternity
Approved proposed merger of subsidiary Osel Healthcare Private Limited with step-down subsidiary SFL Hearing Solutions Private Limited
Re-appointed Managing Director Rajendra Mishra and Whole-time Director Mukesh Sinha for 3-year terms starting January 16, 2027
👀 What to Watch
Monitor voting outcomes at the upcoming AGM on September 25, 2026, and track company announcements regarding the appointment of a new Chief Financial Officer.
